Crinetics Pharmaceuticals

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Crinetics is a publicly traded, clinical stage, pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We currently have programs in the areas of acromegaly, neuroendocrine tumors, carcinoid syndrome, Cushing's disease, congenital adrenal hyperplasia, and congenital hyperinsulinism. All programs are the result of internal discovery efforts and these efforts continue to build new programs for entry into our growing pipeline.
Ticker:
CRNX
Exchange:
NASDAQ
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2008
Main Therapeutic Focus:
Lead Product in Development:
Paltusotine
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
Director, Business Development
Crinetics Pharmaceuticals